Square Pharmaceuticals PLC. (DSE: SQURPHARMA)

SQURPHARMA Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Cash & Equivalents	48,401	50,094	48,962	43,364	32,564	27,004
Cash & Short-Term Investments	48,401	50,094	48,962	43,364	32,564	27,004
Cash Growth	-4.14%	2.31%	12.91%	33.16%	20.59%	59.03%
Accounts Receivable	2,018	3,421	2,159	1,636	1,520	1,562
Other Receivables	2,483	2,702	1,236	1,280	1,276	966.89
Receivables	4,501	6,122	3,395	2,916	7,681	5,466
Inventory	13,037	12,227	8,214	7,245	5,687	4,597
Prepaid Expenses	37.72	81.62	57.56	46.17	44.98	48.02
Other Current Assets	2,072	1,962	1,718	1,505	1,407	1,297
Total Current Assets	68,057	70,487	62,348	55,076	47,384	38,412
Property, Plant & Equipment	27,471	26,059	27,183	22,884	20,874	20,804
Long-Term Investments	32,659	25,270	22,227	17,492	13,561	12,780
Other Intangible Assets	-	0.11	-	-	-	49.49
Other Long-Term Assets	-	-	-	-	-	100
Total Assets	128,188	121,816	111,758	95,452	81,819	72,146
Accounts Payable	800.53	1,002	625.98	666.17	553.79	716.99
Accrued Expenses	1,143	1,327	1,257	1,121	988.27	1,043
Current Portion of Long-Term Debt	599.12	618.61	200	-	-	-
Current Income Taxes Payable	1,229	356.1	911.5	572.68	978.04	557.9
Other Current Liabilities	956.78	926.1	666.85	818.87	721.46	653.5
Total Current Liabilities	4,728	4,229	3,662	3,179	3,242	2,971
Long-Term Debt	948.89	1,368	1,714	103.71	-	-
Long-Term Deferred Tax Liabilities	721.39	1,022	1,179	1,275	1,213	1,294
Total Liabilities	6,398	6,620	6,555	4,557	4,454	4,265
Common Stock	8,865	8,865	8,865	8,865	8,442	7,890
Additional Paid-In Capital	2,035	2,035	2,035	2,035	2,035	2,035
Retained Earnings	110,439	103,578	93,463	78,855	67,298	57,810
Comprehensive Income & Other	448.2	717.6	839.61	1,139	-410.88	144.65
Total Common Equity	121,787	115,196	105,203	90,895	77,365	67,881
Minority Interest	2.17	0.71	0.47	0.5	-	-
Shareholders' Equity	121,789	115,197	105,203	90,895	77,365	67,881
Total Liabilities & Equity	128,188	121,816	111,758	95,452	81,819	72,146
Total Debt	1,548	1,987	1,914	103.71	-	-
Net Cash (Debt)	56,173	52,697	51,395	47,885	35,256	30,017
Net Cash Growth	5.97%	2.53%	7.33%	35.82%	17.45%	51.06%
Net Cash Per Share	63.37	59.45	57.98	54.02	39.77	33.86
Filing Date Shares Outstanding	886.45	886.45	886.45	886.45	886.45	886.45
Total Common Shares Outstanding	886.45	886.45	886.45	886.45	886.45	886.45
Working Capital	63,328	66,258	58,686	51,898	44,143	35,441
Book Value Per Share	137.39	129.95	118.68	102.54	87.27	76.58
Tangible Book Value	121,787	115,196	105,203	90,895	77,365	67,831
Tangible Book Value Per Share	137.39	129.95	118.68	102.54	87.27	76.52
Land	-	6,632	6,446	6,136	5,711	5,405
Buildings	-	11,716	10,317	9,756	9,744	9,105
Machinery	-	29,322	26,788	25,510	24,061	23,240
Construction In Progress	2,604	1,083	6,388	2,460	724.65	832.48

Source: S&P Capital IQ. Standard template. Financial Sources.